GRANULES

Granules India Limited · NSE · INE101D01020 · F&O · lot 1,075 · 272 sessions on record

₹821.75▼ −24.80 · −2.9%from ₹846.55 the session before · 1 Oct 2026 close · NSE end of day

Open: ₹841.70
High: ₹849.10
Low: ₹814.05
Day's range: ₹354.1% of the previous close
VWAP: ₹826.12close −0.53% from it
Volume, shares: 7.8 L0.51× the 20-session average
Turnover, ₹ crore: 65
Trades: 36,00022 shares per trade
Previous close: ₹846.55−24.80 to the close
Price band, next session: ₹739.60 – ₹903.9510% either side of the close · dynamic, widened in 5% steps when hit

Day range22% of the way up

₹814.05₹849.10

52-week range75% of the way up

₹522.70 1 Oct₹923.65 15 Sept

−11% from the high · +57% from the low

The desk read · 28 Augexpiry 28 Aug · 0 days

long unwinding

futures read

price −2.9% · OI −44.2%

−355.05

futures premium, ₹

−43.2% to spot ₹821.75

0.59

puts per call, by OI

by volume 0.46

460

max pain

−44% from the close

▼ −44.2%

futures OI on the day

−2,800 lots · 3,500 open

Long unwinding into a 0-day expiry: futures OI −44.2% on a −2.9% day, the most call OI sits at 500, the most put OI at 450, max pain 460.

Futures and options

28 Aug close · lot 1,075 · NSE end of day

GRANULES futures closed at ₹466.70, −43.2% to spot, with 100% of open interest in the 28 Aug contract, and the 580 straddle prices a move of about ±14% by expiry.

Futures by expiryall 1 contracts NSE lists on the stock · basis against the spot close ₹821.75

Futures by expiry, basis against the spot close ₹821.75
Expiry	Close ₹	Basis ₹ · %	Annualised %	OI lots · on the day	Share of OI %	Contracts traded
28 Aug0 days	₹466.70	−355.05−43.2%	0.00%	3,500▼ −44.2% · −2,800 lots	100	4,900

0.00% of futures OI sits beyond the 28 Aug contract · 28 of 41 listed contracts traded · 7,100 option contracts changed hands

Options28 Aug expiry · 0 days

The 580 straddle closed at ₹111.05 (call 0.05 + put 111.00), pricing a move of about ±14% by the 28 Aug expiry. In the last 271 windows of 1 sessions, GRANULES moved more than that 0 times.

Call OI, lots: 2,30025 L shares
Put OI, lots: 1,40015 L shares
Puts per call, by OI: 0.59by volume 0.46
Max pain: 460−44% from the close
Contracts traded: 28 of 41listed for this expiry

Open interest by strike, lotstop three strikes each side

Calls

Strike

Puts

420

500

410

480

170

350

460

210

450

220

Open interest added on the day, lotsthree largest additions each side

Calls

Strike

Puts

+8.0

580

490

+1.0

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it

272 sessions on file · from 28 Aug

GRANULES close
Nifty 50, rebased

Session read · latest close: 1 Oct 2026
Close ₹ · day %: ₹821.75▼ −2.9% on the previous close
Against Nifty 50: Nifty −0.9%−2.1 pp difference on the day
Against the averages: below 20 · below 5020-session ₹865.99 (−5.1%) · 50-session ₹853.35 (−3.7%)
Volume: 0.51×the previous 20 sessions · 7.8 L shares
Extremes on the day: none

The market after the news

close against the last close before each bulletin · Nifty 50 over the same sessions

After the last 5 bulletins, GRANULES closed higher five sessions later in 0 of 5.

Close after each bulletin on the day, one session later and five sessions later, with Nifty 50 and futures open interest
Bulletin	Day of the news	1 session later	5 sessions later	Futures OI on the day
18 SeptGranules India promoter sells 7% stake for ₹1,500 crore	0.0%Nifty +0.3% · −0.3 pp	▼ −1.3%Nifty −0.1% · −1.2 pp	▼ −2.8%Nifty −2.4% · −0.3 pp	—
16 SeptGranules India promoter sells 6.9% stake for ₹1,509 crore	▼ −4.2%Nifty +0.4% · −4.7 pp	▼ −0.3%Nifty +0.7% · −0.9 pp	▼ −1.4%Nifty +1.4% · −2.8 pp	—
15 SeptGranules India promoter sells 6.9% stake for ₹1,509 crore	▼ −4.2%Nifty +0.4% · −4.7 pp	▼ −0.3%Nifty +0.7% · −0.9 pp	▼ −1.4%Nifty +1.4% · −2.8 pp	—
23 JulGranules India Q1 profit exceeds estimates, target raised	▼ −0.1%Nifty −0.5% · +0.4 pp	▼ −2.4%Nifty −0.9% · −1.4 pp	▼ −2.3%Nifty +1.3% · −3.7 pp	—
21 JulGranules India reports strong Q1 with 22% revenue growth	▼ −2.5%Nifty −0.8% · −1.7 pp	▼ −2.6%Nifty −1.3% · −1.3 pp	▼ −3.9%Nifty +0.3% · −4.1 pp	—

5 of 5 bulletins

Quarterly results

consolidated · latest filed 21 Jul, 02:17 pm IST · NSE filings

Revenue ₹1,477 cr; profit ₹180 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session

Quarterly results of GRANULES on the consolidated basis with the market's move on the first session after each filing
Quarter	Revenue ₹ cr	Revenue YoY	Profit ₹ cr	Profit YoY	EPS ₹	Market on the day
Jun 2026filed 21 Jul	₹1,477 cr	—	₹180 cr	—	7.12	▼ −0.1%Nifty −0.2% · +0.2 pp
Mar 2026filed 29 Apr · audited	₹1,471 cr	—	₹202 cr	—	8.23	▼ −0.7%Nifty −0.7% · +0.1 pp

Fundamentals

consolidated · filings to Jun 2026 · close ₹821.75 on 1 Oct

4.0 times book value, a 0.21% dividend yield, market cap ₹20,000 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing

Market cap: ₹20,000 cron 1 Oct · free float ₹13,000 cr
Price to earnings: —fewer than four consecutive quarters filed
Trailing EPS: —fewer than four consecutive quarters filed
Price to book: 4.0consolidated · balance sheet to Mar 2026
Book value a share: ₹205.21consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity: 0.26borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity: —needs two filed balance sheets
Dividend yield: 0.21%₹1.75 a share in 365 days
Face value: ₹1a share
Shares outstanding: 25 cron 1 Oct

Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated

Revenue, trailing 12 months: —fewer than four consecutive quarters filed
Revenue growth, 12 months: —needs eight consecutive quarters filed
Revenue 3-year CAGR: —needs twelve consecutive quarters filed
Profit, trailing 12 months: —fewer than four consecutive quarters filed
Profit growth, 12 months: —needs eight consecutive quarters filed
Profit 3-year CAGR: —needs twelve consecutive quarters filed

PeersBSE sub-group Pharmaceuticals · F&O stocks with filings on record · industry P/E 38, market caps over trailing profit of 13 stocks

Stocks in the BSE sub-group Pharmaceuticals with market cap, price to earnings and price to book
Stock	Market cap ₹	P/E	P/B	Close ₹
SUNPHARMASun Pharmaceutical Industries Limited	4,30,000 cron 1 Oct	36consolidated	5.2	₹1,801.00
DIVISLABDivi's Laboratories Limited	2,50,000 cron 1 Oct	52consolidated	15	₹9,249.00
TORNTPHARMTorrent Pharmaceuticals Limited	1,80,000 cron 1 Oct	76consolidated	10	₹4,767.30
ZYDUSLIFEZydus Lifesciences Limited	1,10,000 cron 1 Oct	26consolidated	3.9	₹1,145.70
CIPLACipla Limited	1,10,000 cron 1 Oct	32consolidated	3.1	₹1,344.00
LAURUSLABSLaurus Labs Limited	1,10,000 cron 1 Oct	85consolidated	20	₹1,984.00
MANKINDMankind Pharma Limited	1,00,000 cron 1 Oct	51consolidated	6.3	₹2,535.00
DRREDDYDr. Reddy's Laboratories Limited	1,00,000 cron 1 Oct	31consolidated	2.6	₹1,206.20
AUROPHARMAAurobindo Pharma Limited	96,000 cron 1 Oct	26consolidated	2.5	₹1,676.80
LUPINLupin Limited	93,000 cron 1 Oct	17consolidated	4.1	₹2,031.20
GLENMARKGlenmark Pharmaceuticals Limited	66,000 cron 1 Oct	37consolidated	6.3	₹2,331.00
ALKEMAlkem Laboratories Limited	62,000 cron 1 Oct	29consolidated	4.3	₹5,220.00
BIOCONBiocon Limited	60,000 cron 1 Oct	110consolidated	1.6	₹370.70
ABBOTINDIAAbbott India Limited	57,000 cron 1 Oct	—	—	₹26,840.00
IPCALABIPCA Laboratories Limited	49,000 cron 1 Oct	—	5.2	₹1,943.20
GLANDGland Pharma Limited	47,000 cron 1 Oct	—	4.6	₹2,874.40
GLAXOGlaxoSmithKline Pharmaceuticals Limited	47,000 cron 1 Oct	—	21	₹2,771.10
AJANTPHARMAjanta Pharma Limited	45,000 cron 1 Oct	—	9.9	₹3,581.00
EMCUREEmcure Pharmaceuticals Limited	37,000 cron 1 Oct	—	7.4	₹1,944.60
WOCKPHARMAWockhardt Limited	34,000 cron 1 Oct	—	6.4	₹2,083.90
SAILIFESai Life Sciences Limited	33,000 cron 1 Oct	—	13	₹1,541.20
NEULANDLABNeuland Laboratories Limited	28,000 cron 1 Oct	—	15	₹21,505.00
RUBICONRubicon Research Limited	27,000 cron 1 Oct	—	21	₹1,630.90
PPLPHARMAPiramal Pharma Limited	26,000 cron 1 Oct	—	3.2	₹197.95
ACUTAASAcutaas Chemicals Limited	26,000 cron 1 Oct	—	15	₹3,196.50
SHILPAMEDShilpa Medicare Limited	21,000 cron 1 Oct	—	8.0	₹1,064.10
GRANULESGranules India Limited	20,000 cron 1 Oct	—	4.0	₹821.75
CAPLIPOINTCaplin Point Laboratories Limited	20,000 cron 1 Oct	—	5.5	₹2,631.90
PFIZERPfizer Limited	18,000 cron 1 Oct	—	4.2	₹3,858.90
ONESOURCEOnesource Specialty Pharma Limited	17,000 cron 1 Oct	—	3.0	₹1,508.00
COHANCECohance Lifesciences Limited	17,000 cron 1 Oct	—	4.3	₹451.30
ALIVUSAlivus Life Sciences Limited	17,000 cron 1 Oct	—	5.1	₹1,374.20
ERISEris Lifesciences Limited	16,000 cron 1 Oct	—	4.2	₹1,189.80
NATCOPHARMNatco Pharma Limited	16,000 cron 1 Oct	—	1.8	₹821.30
APLLTDAlembic Pharmaceuticals Limited	16,000 cron 1 Oct	—	2.8	₹815.25
JUBLPHARMAJubilant Pharmova Limited	16,000 cron 1 Oct	—	2.2	₹999.30
ASTRAZENAstraZeneca Pharma India Limited	15,000 cron 1 Oct	—	17	₹6,031.00
MARKSANSMarksans Pharma Limited	15,000 cron 1 Oct	—	4.8	₹325.60
CONCORDBIOConcord Biotech Limited	14,000 cron 1 Oct	—	7.1	₹1,374.10
AKUMSAkums Drugs and Pharmaceuticals Limited	13,000 cron 1 Oct	—	3.8	₹813.10
CORONACORONA Remedies Limited	12,000 cron 1 Oct	—	17	₹2,029.40
BLUEJETBlue Jet Healthcare Limited	10,000 cron 1 Oct	—	7.5	₹541.80
VIYASHViyash Scientific Limited	10,000 cron 1 Oct	—	3.3	₹231.75
STARStrides Pharma Science Limited	10,000 cron 1 Oct	—	3.2	₹1,084.80
PGHLProcter & Gamble Health Limited	8,900 cron 1 Oct	—	17	₹5,360.00
AARTIPHARMAarti Pharmalabs Limited	8,800 cron 1 Oct	—	4.1	₹968.50
SANOFICONRSanofi Consumer Healthcare India Limited	8,700 cron 1 Oct	—	25	₹3,787.20
SYMBIOTECSymbiotec Pharmalab Limited	7,700 cron 1 Oct	—	—	₹1,198.00
SUPRIYASupriya Lifescience Limited	7,500 cron 1 Oct	—	6.3	₹931.00
MOREPENLABMorepen Laboratories Limited	7,300 cron 1 Oct	—	5.9	₹133.70
SANOFISanofi India Limited	7,000 cron 1 Oct	—	8.5	₹3,037.40
INNOVACAPInnova Captab Limited	6,700 cron 1 Oct	—	6.1	₹1,168.00
SPARCSun Pharma Advanced Research Company Limited	6,300 cron 1 Oct	—	4.7	₹194.15
SENORESSenores Pharmaceuticals Limited	6,200 cron 1 Oct	—	6.4	₹1,349.60
IOLCPIOL Chemicals and Pharmaceuticals Limited	6,100 cron 1 Oct	—	3.4	₹209.40
ORCHPHARMAOrchid Pharma Limited	5,900 cron 1 Oct	—	4.6	₹990.00
FDCFDC Limited	5,500 cron 1 Oct	—	2.2	₹335.90
GUJTHEMGujarat Themis Biosyn Limited	5,000 cron 1 Oct	—	—	₹381.80
NOVARTINDNovartis India Limited	4,900 cron 1 Oct	—	—	₹1,965.00
RPGLIFERPG Life Sciences Limited	4,800 cron 1 Oct	—	8.0	₹2,930.70
SMSPHARMASMS Pharmaceuticals Limited	4,400 cron 1 Oct	—	5.6	₹471.30
GUFICBIOGufic Biosciences Limited	4,200 cron 1 Oct	—	6.3	₹418.40
AARTIDRUGSAarti Drugs Limited	3,800 cron 1 Oct	—	2.5	₹421.00
UNICHEMLABUnichem Laboratories Limited	3,800 cron 1 Oct	—	1.4	₹535.05
KPLKwality Pharmaceuticals Limited	3,700 cron 1 Oct	—	—	₹3,564.40
SOLARASolara Active Pharma Sciences Limited	3,400 cron 1 Oct	—	2.7	₹714.85
INDSWFTLABInd-Swift Laboratories Limited	3,400 cron 1 Oct	—	2.5	₹395.15
SHUKRAPHARShukra Pharmaceuticals Limited	2,700 cron 1 Oct	—	—	₹61.80
HIKALHikal Limited	2,700 cron 1 Oct	—	2.2	₹218.15
VENUSREMVenus Remedies Limited	2,400 cron 1 Oct	—	3.6	₹1,796.70
DCALDishman Carbogen Amcis Limited	2,400 cron 1 Oct	—	0.35	₹150.35
INDOCOIndoco Remedies Limited	2,300 cron 1 Oct	—	2.5	₹251.75
SAIPARENTSai Parenterals Limited	2,300 cron 1 Oct	—	4.7	₹523.65
SYNCOMFSyncom Formulations (India) Limited	2,300 cron 1 Oct	—	5.4	₹23.95
FREDUNFredun Pharmaceuticals Limited	2,200 cron 1 Oct	—	—	₹1,355.20
WINDLASWindlas Biotech Limited	2,200 cron 1 Oct	—	—	₹1,082.40
PANACEABIOPanacea Biotec Limited	2,200 cron 1 Oct	—	2.6	₹359.05
HESTERBIOHester Biosciences Limited	1,800 cron 1 Oct	—	4.9	₹2,126.80
NGLFINENGL Fine-Chem Limited	1,800 cron 1 Oct	—	5.5	₹2,924.00
AHCLAnlon Healthcare Limited	1,700 cron 1 Oct	—	6.8	₹32.85
FERMENTAFermenta Biotech Limited	1,600 cron 1 Oct	—	—	₹553.25
JAGSNPHARMJagsonpal Pharmaceuticals Limited	1,500 cron 1 Oct	—	5.5	₹231.75
AMRUTANJANAmrutanjan Health Care Limited	1,500 cron 1 Oct	—	4.0	₹513.20
KOPRANKopran Limited	1,400 cron 1 Oct	—	2.6	₹282.05
BPLPHARMABharat Parenterals Limited	1,200 cron 1 Oct	—	—	₹1,720.40
LINCOLNLincoln Pharmaceuticals Limited	1,200 cron 1 Oct	—	1.5	₹582.05
BAJAJHCAREBajaj Healthcare Limited	1,100 cron 1 Oct	—	2.0	₹322.95
SIGACHISigachi Industries Limited	1,100 cron 1 Oct	—	2.0	₹28.35
THEMISMEDThemis Medicare Limited	1,000 cron 1 Oct	—	2.6	₹113.20
SGRLShree Ganesh Remedies Limited	890 cron 1 Oct	—	—	₹694.25
ANUHPHRAnuh Pharma Limited	860 cron 1 Oct	—	2.4	₹85.85
ZIMLABZim Laboratories Limited	740 cron 1 Oct	—	2.5	₹137.00
WANBURYWanbury Limited	690 cron 1 Oct	—	4.8	₹198.00
ALBERTDAVDAlbert David Limited	490 cron 1 Oct	—	1.3	₹856.70
MEDICAMEQMedicamen Biotech Limited	470 cron 17 Sept	—	1.7	₹346.30
HALEOSLABSHALEOS LABS LIMITED	450 cron 1 Oct	—	2.0	₹1,490.00
JENBURPHJenburkt Pharmaceuticals Limited	400 cron 1 Oct	—	—	₹915.25
AAREYDRUGSAarey Drugs & Pharmaceuticals Limited	290 cron 1 Oct	—	2.0	₹103.85
NECLIFENectar Lifesciences Limited	200 cron 1 Oct	—	0.34	₹10.25
MEDICOMedico Remedies Limited	180 cron 1 Oct	—	2.4	₹21.85
BALPHARMABal Pharma Limited	170 cron 1 Oct	—	2.0	₹105.75
BROOKSBrooks Laboratories Limited	160 cron 1 Oct	—	1.3	₹54.80
KREBSBIOKrebs Biochemicals and Industries Limited	150 cron 1 Oct	—	—	₹68.05
PARNAXLABParnax Lab Limited	130 cron 1 Oct	—	—	₹113.15
ALPAAlpa Laboratories Limited	120 cron 1 Oct	—	0.67	₹59.25
MAKERSLMakers Laboratories Limited	110 cron 1 Oct	—	—	₹183.50
SUNLOCSunil Healthcare Limited	72 cron 1 Oct	—	—	₹70.10
VINEETLABVineet Laboratories Limited	69 cron 1 Oct	—	1.5	₹35.90
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited	48 cron 1 Oct	—	2.2	₹29.30
MANGALAMMangalam Drugs And Organics Limited	46 cron 1 Oct	—	0.45	₹29.15
MEDICAPQMedi Caps Limited	31 cron 17 Sept	—	—	₹24.80
ORTINGLOBEORTIN GLOBAL LIMITED	12 cron 1 Oct	—	9.5	₹14.50
AMANTAAmanta Healthcare Limited	—	—	—	—
AMBALALSAAmbalal Sarabhai Enterprises Limited	—	—	—	—
BAFNAPHBafna Pharmaceuticals Limited	—	—	—	—
BLISSGVSBliss GVS Pharma Limited	—	—	—	—
KILITCHKilitch Drugs (India) Limited	—	—	—	—
LASALasa Supergenerics Limited	—	—	—	—
LYKALABSLyka Labs Limited	—	—	—	—
NATCAPSUQNatural Capsules Limited	—	—	—	—
VALIANTLABValiant Laboratories Limited	—	—	—	—
VIVIMEDLABVivimed Labs Limited	—	—	—	—

Shareholding

quarter to 16 Sept · none pledged · NSE filings

Promoters hold 37.4%, foreign portfolio investors 20.3%, mutual funds 4.2% and insurance companies 7.2%, as filed for the quarter to 16 Sept.

37.4%20.3%19.4%

By category, last 3 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file

Shareholding of GRANULES by category over the last 3 quarters with the change against the previous quarter
Category	16 Sept	30 Jun	31 Mar
Promoters	37.39▼ −0.63 pp	38.020.00 pp	38.02
Foreign portfolio investors	20.29▲ +2.79 pp	17.50▲ +2.19 pp	15.31
Mutual funds	4.18▲ +0.73 pp	3.45▲ +0.60 pp	2.85
Insurance companies	7.17▼ −1.64 pp	8.81▼ −1.59 pp	10.40
Banks and financial institutions	4.05▲ +0.20 pp	3.85▲ +0.09 pp	3.76
Individual investors	19.40▼ −0.33 pp	19.73▼ −1.75 pp	21.48
Bodies corporate	5.51▼ −0.80 pp	6.31▲ +0.61 pp	5.70
Others	2.02▼ −0.31 pp	2.33▼ −0.16 pp	2.49

Corporate actions

NSE and BSE records

Nothing upcoming on record; the last was a dividend of ₹1.75 a share, ex-date 30 Jul 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios

Corporate actions of GRANULES, upcoming first, then the most recent
Ex-date	Action	Amount or ratio	Record date	Source
recent
30 Jul 2026	dividend	₹1.75	30 Jul 2026	NSE
31 Jul 2025	dividend	₹1.50	31 Jul 2025	NSE
30 Jul 2024	dividend	₹1.50	—	NSE

Calendaras notified to the exchange

Next results: —no board meeting notified yet
Dividends in 365 days: ₹1.75a share · ex-dates inside the year
Last dividend: ₹1.75ex-date 30 Jul 2026

Price history

272 sessions on record · to 1 Oct · NSE end of day

GRANULES is −1.2% over 20 sessions against Nifty's −6.2%, 11% below its 52-week high, realised volatility 38% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions

Returns of the stock and Nifty 50 over six windows, longest first
Window	From ₹	GRANULES %	Nifty 50 %	Difference pp
250 sessionssince 26 Sept	₹515.92	▲ +59%	▼ −9.1%	+68
120 sessionssince 9 Apr	₹635.49	▲ +29%	▼ −5.7%	+35
60 sessionssince 8 Jul	₹859.57	▼ −4.4%	▼ −6.1%	+1.7
20 sessionssince 2 Sept	₹831.73	▼ −1.2%	▼ −6.2%	+5.0
5 sessionssince 24 Sept	₹852.97	▼ −3.7%	▼ −2.8%	−0.88
1 sessionsince 30 Sept	₹846.55	▼ −2.9%	▼ −0.88%	−2.0

Averages of the closeclose against each average

5-session average: ₹851.02close −3.4% from it
20-session average: ₹865.99close −5.1% from it
50-session average: ₹853.35close −3.7% from it
200-session average: ₹717.38close +15% from it

Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average

Average true range, 14: ₹303.7% of the close
Average day's range, 20: ₹293.5% of the close
Volume against 20 sessions: 0.51×7.8 L vs 15 L average

Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell

Realised volatility, 20: 38%≈ ±2.4% a session · moved more than that on 6 of 20
Realised volatility, 60: 29%≈ ±1.8% a session · moved more than that on 21 of 60
Realised volatility, 250: 29%≈ ±1.8% a session · moved more than that on 74 of 250
Beta to Nifty, 60: 0.84moved with Nifty on 35 of 60 sessions
Beta to Nifty, 250: 0.84moved with Nifty on 145 of 250 sessions

Up and down sessionscloses above and below the previous close

Last 20 sessions: 9 up · 11 downof 20
Last 60 sessions: 28 up · 32 downof 60
Last 250 sessions: 130 up · 119 downof 249
Best session, 250: ▲ +6.3%22 Jan
Worst session, 250: ▼ −4.2%16 Sept

Granules India Limited is in 15 NSE indices

all 15 indices

5 bulletins on GRANULES

latest 18 Sept 2026

Beats in the coverage

Pharma5

September 2026

18 Sept Granules India promoter sells 7% stake for ₹1,500 croreKrishna Prasad Chigurupati, promoter of Granules India, sold a 7% stake (1.72 crore shares) for over ₹1,500 crore to support growth plans. The shares were sold at ₹872.50 each, a 3% discount to the prior closing price.High 16 Sept Granules India promoter sells 6.9% stake for ₹1,509 croreGranules India is under scrutiny after promoter Krishna Prasad sold 6.9% stake for ₹1,509 crore via a block deal. This transaction raises questions about the promoter's future plans and market sentiment regarding the company.Medium 15 Sept Granules India promoter sells 6.9% stake for ₹1,509 croreGranules India is under scrutiny after promoter Krishna Prasad sold 1.72 crore shares, or 6.9% of equity, for ₹1,509 crore via a block deal. This move may affect market perception and investor sentiment regarding the company's future.Medium

July 2026

23 Jul Granules India Q1 profit exceeds estimates, target raisedGranules India reported Q1 FY2027 profit after tax up 11% and gross margin at 65.6%, exceeding estimates. The shift towards complex generics, now 50% of sales, signals strong demand, particularly in the U.S. market.High 21 Jul Granules India reports strong Q1 with 22% revenue growthGranules India reported Q1 results with revenue up 22% to ₹1,476 cr and net profit increasing 60% to ₹180 cr. The EBITDA margin expanded to 23%, indicating strong operational performance.High

About Granules India Limited

exchange masters as of 18 Sept 2026 · classification by BSE

Company: Granules India Limited
Exchange: NSE · BSE 532482, group A
Listed on NSE: 20 Jun 2005
Classification: Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
Index: BSE 500
Face value: ₹1 a share
ISIN: INE101D01020
Sessions on record: 272
Price source: NSE UDiFF bhavcopy · end of day · delayed
Filings: NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed: 2 Oct, 02:30 am IST
Bulletins: 5 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.